Biological and Surgical Factors Key to Predicting Keloid Recurrence After Excision, Study Finds

Ilustrasi by AI

A systematic review published in September 2026 by Dr. Badariyatud Dini at Maulana Malik Ibrahim State Islamic University investigated the patient, lesion, and surgical factors that predict keloid scar recurrence after surgical excision. The study synthesized global primary evidence published between January 2020 and September 2026. The findings demonstrate that post-operative keloid regrowth is driven by an interactive combination of inherited genetic susceptibility, lesion size, biological activity, mechanical tension, and wound healing complications such as infection. This comprehensive prognostic framework helps healthcare providers identify high-risk individuals and tailor perioperative care to prevent keloid regrowth.

The Growing Burden of Persistent Keloid Scarring

Keloids are pathological fibroproliferative scars that grow beyond the boundaries of an original skin injury. They cause physical discomfort—including chronic pain and itching—as well as severe cosmetic deformity and psychosocial distress. While surgical excision is often required for large, symptomatic, or treatment-resistant scars, surgical removal alone frequently fails because it does not stop the body's abnormal scar-forming response. Understanding why keloids recur in certain patients despite surgical treatment and follow-up therapy remains a central challenge in plastic surgery and dermatology.

Systematic Method for Analyzing Risk Predictors

Dr. Badariyatud Dini conducted a systematic review following the PRISMA 2020 guidelines and frameworks for prognostic factor research. Literature searches were executed across databases including Scopus, PubMed/MEDLINE, Embase, Web of Science, and CENTRAL for human studies published from January 2020 to September 2026.

From 1,142 identified records, 24 primary observational cohort and clinical studies evaluating patient, lesion, and surgical predictors were included in the qualitative synthesis. Risk of bias was appraised using the Quality In Prognosis Studies (QUIPS) tool, and certainty of evidence was evaluated using adapted GRADE criteria. Prognostic factors were grouped across three primary domains:

  • Patient-related characteristics: Age, sex, family history, and systemic biomarkers.
  • Lesion-related characteristics: Anatomical location, size, biological activity, and mechanical tension.
  • Surgery-related conditions: Excision techniques, surgical margins, wound dehiscence, local tension, and post-operative infection.

Post-operative adjuvant therapies—such as radiation, steroid injections, and compression—were evaluated separately as treatment modifiers rather than baseline risk factors.

Key Findings on Keloid Recurrence Predictors

The synthesis revealed that keloid recurrence risk is determined by specific biological and surgical predictors rather than treatment protocols alone:

  • Family History and Genetics: Inherited susceptibility plays a major role, with familial keloid history consistently increasing recurrence risk across diverse populations.
  • Lesion Size and Biological Activity: Larger scars (such as those measuring $\ge 2\text{ cm}$ or having large diameters) and lesions with high biological activity scores show higher rates of recurrence.
  • Anatomical Site and Mechanical Tension: High-tension body regions—such as the chest, shoulders, and earlobes—demonstrate variable and frequently elevated recurrence rates compared to low-tension regions.
  • Post-Operative Infection and Complications: Wound-related complications and infections after surgery were strongly associated with keloid regrowth. In multivariable models, post-operative complications increased the odds of recurrence significantly.
  • Biomarkers: Isolated systemic markers, such as pre-operative serum vitamin D levels, showed no independent predictive value for recurrence.

Real-World Impact and Clinical Implications

These findings shift the paradigm of scar management from procedure-focused care to personalized, risk-adapted management. Clinicians can use these predictors prior to surgery to identify high-risk patients based on family history, scar size, and anatomical tension. Furthermore, preventing post-operative wound infection and minimizing wound tension emerge as modifiable clinical targets that directly reduce the likelihood of recurrence.

"Keloid recurrence after excision is determined by the interaction of patient susceptibility, lesion characteristics, anatomical and mechanical factors, surgical conditions, and postoperative wound events," stated Dr. Badariyatud Dini of Maulana Malik Ibrahim State Islamic University. "These findings challenge the conventional view that recurrence mainly reflects inadequate excision or insufficient adjuvant therapy."

Author Profile

Dr. Badariyatud Dini holds a medical degree (dr.) and serves as a researcher and academic faculty member at Maulana Malik Ibrahim State Islamic University, Indonesia. Her field of expertise encompasses wound healing, surgical prognosis, scar management, and clinical research methodologies in dermatology and surgery.

Source

 


Posting Komentar

0 Komentar